ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Mechanistic Design of Graphdiyne-Based Multimodal Sensing Integrating Machine Learning and Photothermal Dynamics for Precision Recognition and On-Demand Inactivation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Rapid and accurate detection of pathogenic bacteria remains essential for infection control and timely treatment. Here, we report a graphdiyne (GDY)-based self-powered biosensing platform that integrates CRISPR/Cas12a molecular recognition with GDY/Au nanoparticle-engineered bioelectrodes for multimodal detection and photothermal inactivation of Vibrio parahaemolyticus. The ultrathin GDY framework provides a high-surface-area scaffold for uniform Au nanoparticle dispersion, facilitating interfacial charge transfer and enhancing enzyme-mediated redox kinetics at the bioanode. Target-triggered CRISPR/Cas12a trans-cleavage regulates the release of glucose oxidase from a hairpin probe, enabling a self-powered electrochemical readout driven by glucose oxidation. In parallel, HRP-catalyzed oxidation of TMB generates oxTMB with strong near-infrared absorbance, providing complementary colorimetric and photothermal (808 nm) outputs and enabling in situ bacterial inactivation. The electrochemical, colorimetric, and thermal modes exhibit concentration-dependent responses with limits of detection of 0.34, 0.41, and 0.78 CFU mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.